Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0001041,
umls-concept:C0020885,
umls-concept:C0027882,
umls-concept:C0030685,
umls-concept:C0085979,
umls-concept:C0205314,
umls-concept:C0216492,
umls-concept:C0391871,
umls-concept:C0450442,
umls-concept:C0679622,
umls-concept:C0680255,
umls-concept:C1283071,
umls-concept:C1304890,
umls-concept:C1627358,
umls-concept:C1963578,
umls-concept:C2349975
|
pubmed:issue |
4
|
pubmed:dateCreated |
1994-9-14
|
pubmed:abstractText |
KW-5092 ((1-[2-[[[5-(piperidinomethyl)-2-furanyl]methyl]amino]ethyl]-2- imidazolidinylidene) propanedinitrile fumarate) is a novel gastroprokinetic agent with acetylcholinesterase (AChE) inhibitory activity. The present study examined the effects of KW-5092 on intestinal contraction and on acetylcholine (ACh) release in the isolated longitudinal muscle-myenteric plexus preparation of guinea pig ileum. In the electrically stimulated preparation, KW-5092 enhanced the contraction at 10(-9) M to 3 x 10(-6) M and potentiated the ACh release at 10(-8) M to 3 x 10(-6) M. In the unstimulated preparation, KW-5092 at 10(-8) M to 10(-4) M evoked the contraction and ACh release. Both the contraction and the ACh release by KW-5092 were abolished by tetrodotoxin (10(-7) M) or removal of external Ca2+, and the evoked contraction was abolished by atropine (10(-7) M). The ACh release by KW-5092 was not affected by hexamethonium (3 x 10(-5) M), suggesting that the nicotinic receptor is not involved in the ACh release. Neostigmine, whose AChE inhibitory activity is equipotent to that of KW-5092, did not evoke ACh release even at 3 x 10(-6) M, indicating that the ACh release by KW-5092 is not due to its AChE inhibitory activity. The present results suggest that KW-5092 evokes ACh release by stimulating a cholinergic pathway and that the ACh release by KW-5092 may contribute to its gastroprokinetic effects.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0021-5198
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
64
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
289-95
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8057530-Acetylcholine,
pubmed-meshheading:8057530-Animals,
pubmed-meshheading:8057530-Dose-Response Relationship, Drug,
pubmed-meshheading:8057530-Electric Stimulation,
pubmed-meshheading:8057530-Guinea Pigs,
pubmed-meshheading:8057530-Ileum,
pubmed-meshheading:8057530-Imidazoles,
pubmed-meshheading:8057530-Muscle, Smooth,
pubmed-meshheading:8057530-Muscle Contraction,
pubmed-meshheading:8057530-Myenteric Plexus,
pubmed-meshheading:8057530-Neurons,
pubmed-meshheading:8057530-Nitriles
|
pubmed:year |
1994
|
pubmed:articleTitle |
Enhancement by KW-5092, a novel gastroprokinetic agent, of the release of acetylcholine from enteric neurons in the guinea pig ileum.
|
pubmed:affiliation |
Department of Pharmacology, Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, Japan.
|
pubmed:publicationType |
Journal Article,
In Vitro
|